New drug appears to relieve Parkinson's psychosis

11/6/2013 | Nursing Times (U.K.) (free registration)

A new non-dopaminergic drug known as pimavanserin was found to be safe and effective in relieving psychotic symptoms in Parkinson's disease and could be useful for Alzheimer's disease and other similar conditions. The trial, which involved 199 patients with psychotic symptoms associated with Parkinson's, showed that 37% of those who received pimavanserin showed improvement in psychotic symptoms compared with 14% of the placebo group. Details of the Phase III trial were published in The Lancet.

View Full Article in:

Nursing Times (U.K.) (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT